Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Antiseptic Cleansing Prevents Deaths in Newborns

By HospiMedica International staff writers
Posted on 15 Mar 2015
A new review concludes that using a low-cost antiseptic to cleanse the umbilical cord after birth could help reduce infant death rates in developing countries by 12%.

Researchers at the Indian Council of Medical Research (New Delhi, India), Kasturba Hospital (Delhi, India), and other institutions conducted a systemic review of 12 trials involving chlorhexidine cleansing in over 87,000 newborns worldwide. More...
Seven of the trials took place in South-East Asia, two in Africa, two in Europe, and one South America. Of the 12 trials, the five carried out in community settings, which involved 72,030 newborns (including home births), provided the highest quality evidence.

The results showed that cleansing umbilical cords with chlorhexidine reduced infant deaths by 12%, compared to keeping cords dry. Using chlorhexidine also halved the number of newborn babies that suffered from omphalitis, a swelling of the cord stump commonly caused by bacterial infections. The results also revealed, however, that maternal vaginal chlorhexidine use probably leads to no difference in neonatal mortality or risk of infections in the hospital setting. The review was published in the March 2015 issue of the Cochrane Library.

“The greatest benefits were seen in the South-East Asian studies. The results from African studies are less convincing, so we would like to see whether the results from ongoing trials in Zambia and Tanzania can substantiate this evidence,” said lead author Anju Sinha, MD, of the Indian Council of Medical Research. “Based on our review, using chlorhexidine to clean the umbilical cord saves newborn babies lives.”

Chlorhexidine salts dissociate and release the positively charged chlorhexidine cation molecule, which causes a bactericidal effect by binding to negatively charged cell walls. At low concentrations, a bacteriostatic effect occurs; at high concentrations, membrane disruption results in cell death. It can be applied topically as a gel, wash, or powder. In maternity care, it can be used either as a vaginal disinfectant to prevent the spread of bacteria from mother to baby, or as a cleansing agent for the newborn baby's skin or umbilical cord.

Related Links:

Indian Council of Medical Research
Kasturba Hospital



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Portable Jaundice Management Device
Nymphaea
Xenon Light Source
CLV-S400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.